Relationship between TIGIT expression on T cells and the prognosis of patients with hepatocellular carcinoma
Patients with HCC that have a high TIGIT expression on their T cells exhibited poorer baseline characteristics, immunosuppressive status, and prognosis after receiving TACE combined with apatinib and camrelizumab and maybe more suited to receive TACE combined with apatinib treatment instead.
Authors
- Fang Ting Li
- Hai Liang Li
- Yuan Guo (ORCID: https://orcid.org/0000-0003-4607-7356)
- Xiong Yang
- Wei Li Xia
- Hong-Tao Hu (ORCID: https://orcid.org/0000-0002-5432-4014)
- Wen Zhu
Institutions
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1186/s12885-024-12876-5
- Citations
- 4
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- Natural Science Foundation of Henan Province